Coherus BioSciences Inc (CHRS)

29.89
NASDAQ : Health Care
Prev Close 29.89
Day Low/High 0.00 / 0.00
52 Wk Low/High 12.04 / 31.84
Avg Volume 413.00K
Exchange NASDAQ
Shares Outstanding 43.38M
Market Cap 1.31B
EPS -6.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

16 Biopharma Companies Besides Medivation That Are Attractive Targets

16 Biopharma Companies Besides Medivation That Are Attractive Targets

Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.

Coherus BioSciences Provides Update On IPRs

Coherus BioSciences Provides Update On IPRs

Patent Trial and Appeal Board Institutes Two Additional IPRs Against AbbVie's Patents

Coherus Presents Study Results Demonstrating Equivalence Of Its CHS-0214 Biosimilar To Etanercept

Coherus Presents Study Results Demonstrating Equivalence Of Its CHS-0214 Biosimilar To Etanercept

Biosimilar to etanercept meets primary endpoint

Coherus BioSciences Advances Differentiated IP Strategy For Humira Market Access

Coherus BioSciences Advances Differentiated IP Strategy For Humira Market Access

USPTO Issued Coherus U.S. Patents 9,340,611; 9,340,612 and 9,346,880

2 Big -- and Mispriced -- Biotech Stocks

AbbVie and Gilead Sciences are worth accumulating in a long and deep bear market for biotech.

Coherus BioSciences Provides Update On '135 IPR

Coherus BioSciences Provides Update On '135 IPR

Patent Trial and Appeal Board Institutes

Coherus BioSciences is Now Oversold (CHRS)

Coherus BioSciences is Now Oversold (CHRS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Coherus BioSciences (CHRS) Is Weak On High Volume Today

Coherus BioSciences (CHRS) Is Weak On High Volume Today

Trade-Ideas LLC identified Coherus BioSciences (CHRS) as a weak on high relative volume candidate

Commit To Buy Coherus BioSciences At $17.50, Earn 35.8% Annualized Using Options

Commit To Buy Coherus BioSciences At $17.50, Earn 35.8% Annualized Using Options

Investors eyeing a purchase of Coherus BioSciences Inc stock, but tentative about paying the going market price of $18.75/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $17.50 strike, which has a bid at the time of this writing of $1.80.

Commit To Purchase Coherus BioSciences At $12.50, Earn 37.6% Annualized Using Options

Commit To Purchase Coherus BioSciences At $12.50, Earn 37.6% Annualized Using Options

Investors considering a purchase of Coherus BioSciences Inc shares, but cautious about paying the going market price of $14.47/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May put at the $12.50 strike, which has a bid at the time of this writing of $1.35.